PATENT CLAIM ANALYSIS

Application Number: 16325610
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["435", "232000"]

Abstract:
Provided herein is a genetically modified host cell comprising a heterologous nucleic acid encoding a biofilm dispersal polypeptide that decreases intracellular c-di-GMP levels and enhances the production of lysine and lysine derivatives. Further provided are methods of generating such cell and producing lysine and lysine derivatives using the genetically modified host cell.

Claim (Index 34):
The method of  claim 33 , wherein the biofilm dispersal polypeptide is BdcA or YahA polypeptide.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.45946
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15774820', '15517633', '12772538', '12993399', '09722441']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6070253128218606
- 35 USC 102 Novelty (BERT): 0.5599852847581944
- Combined Prediction Score: 0.6023213100154939
- Mean Citation Score: 317.812236
- Max Citation Score: 459.55585
- Similarity Product: 300.53546674538256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test